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1. Introduction 
Complete decoding of complex eukaryotic genomes is a prerequisite for understanding 
varied gene functions. Gene silencing (point mutations, gene deletions, etc), sub cellular 
localization of proteins, gene expression pattern analysis by promoter activity assay, 
structure-function analysis, and in vitro or in vivo biochemical assays (Hartley et al., 2000; 
Curtis & Grossniklaus, 2003; Earley et al., 2006) are some of the approaches followed for 
understanding gene functions.  
Typically, all the above approaches require the cloning of target genes with or without 
selective mutations, or cloning their promoter fragments into specialized vectors for further 
characterization. While the traditional approach for constructing expression cassettes that is 
based on the restriction enzyme/ligase cloning method is laborious and time consuming, the 
process is often hampered by length of the gene of interest, GC content of the gene, toxicity of 
the gene product to the expressing host and lack of relevant restriction sites for cloning 
purposes. All these factors render the production of expression constructs a significant 
technical obstacle for large-scale functional gene analysis.  
After generating successful cloning/expression constructs, several steps followed are 
screening high number of colonies, avoiding false positive recombinants and requirement of 
dephosphorylation of vectors in case of single site cloning to ensure the generation of 
recombinants with rightly oriented gene of interest and to minimize vector background 
(non-recombinants).  
Screening for recombinants is one of the most crucial and time-consuming steps in molecular 
cloning and several approaches available for this purpose include colony PCR screening, blue 
white screening, screening of recombinants, which have the gene of interest in the MCS region 
of the cloning vehicle, in such a way that the toxic gene reading frame is interrupted making 
the toxic gene inactivated upon insertion of any foreign gene; GFP fluorescence vectors 
wherein upon cloning, the GFP fluorescence disappears, etc. The method for screening of 
bacterial transformants that carry recombinant plasmid with the gene of interest, has become 
more rapid and simple by the use of vectors with visually detectable reporter genes.  
2. Molecular cloning 
A recombinant DNA comprises of two entities namely a vector and the gene of interest 
(GOI). The process of joining vector and any GOI is by making a phosphodiester bond by a 
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process called ligation. The ligation reaction is facilitated with the help of T4 DNA ligase in 
the presence of ATP. If a vector and any target DNA fragments are generated by the action 
of the same restriction endonuclease, they will join by base-pairing due to the compatibility 
of their respective ends. Such a construct is then transformed into a prokaryotic cell, where 
unlimited copies of the construct, an essentially the target DNA sequence is made inside the 
cell.   
2.1 Steps in molecular cloning  
The conventional restriction and ligation cloning protocol involves four major steps namely 
fragmentation of DNA with restriction endonucleases, ligation of DNA fragments to a 
plasmid vector, introduction into bacterial cells by transformation and screening and 
selection of recombinants.  
2.1.1 Selection and preparation of vector and insert 
A cloning vehicle, also termed as a vector, can be classified as a carrier carrying  a gene to 
be transferred from one organism to another. Other cloning vectors include plasmids, 
cosmids, bacteriophage, phagemids and artificial chromosomes. In the early days of 
producing proteins in E. coli, limitations to transcription initiation were believed to lead to 
lower protein expression levels (Gralla, 1990). This event resulted in efforts put into 
construction of expression vectors, which carried strong promoters to enhance mRNA 
yield and a stable mRNA eventually.  The promoters used included phage promoters like 
T7 and T5, the synthetic promoters tac and trc, and the arabinose inducible araBAD 
(Trepe, 2006). Additional vectors that were made available included Lambda promoters, 
PR and PL, (Elvin et al., 1990), rhamnose promoter (Cardona & Valvano, 2005), Trp-lac 
promoter (Chernajovskyi et al., 1983) etc. Certain promoter variants as seen in the 
expression vector pAES25 yield the maximum level of soluble active target protein 
(Broedel & Papciak , 2007). 
Downstream of each specific promoter, there is a multiple cloning site (MCS) for cloning the 
gene to be expressed. While the inducible promoters are used to drive the foreign gene 
expression, the constitutive promoters (Liang et al,., 1999) are used mainly to express the 
antibiotic expression marker genes for plasmid maintenance.  
TA cloning vectors (Zhou & Gomez-Sanchez, 2000; Chen et al., 2009) that takes advantage of 
the well-known propensity of non-proofreading DNA polymerases (e.g., Taq, Tfl, Tth) to 
add a single 3´-A to PCR products are also employed for cloning large PCR fragments. The 
proof-reading polymerases lack 5'-3' proofreading activity and are capable of adding 
adenosine triphosphate residues to the 3' ends of the double stranded PCR product. Such a 
PCR amplified product can then be cloned in any linearized vector with complementary 3' T 
overhangs.  
The GC cloning technology is based on the recent discovery that the above proof-reading 
enzymes similarly add a single 3´-G to DNA molecules, either during PCR or as a separate 
G-tailing reaction to any blunt DNA. GC cloning vectors pSMART® GC and pGC™ Blue 
(commercialized by Lucigen, USA) contain a single 3´-C overhang, which is compatible with 
the single 3´-G overhang on the inserts.  
Mead and coworkers (Mead et al., 1991) report cloning of PCR products without any 
restriction digestion taking advantage of the single 3' deoxyadenylate extension that 
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Thermus aquaticus, Thermus flavus, and Thermococcus litoralis DNA polymerases add to the 
termini of amplified nucleic acid.  
Gateway cloning system is a relatively new trend in the field of molecular cloning, where in 
the site specific recombination system of lambda phage is used (Katzen 2007). This system 
enables the researchers to efficiently transfer DNA fragments between different vector and 
expression systems, without changing the orientation of the gene or its reading frame. The 
specific sequences are called “Gateway att sites” and recombination is facilitated by two 
enzymes “LR clonase” and “BP clonase”. This easy Ligase-free cloning system is very 
beneficial for cloning, combining and transferring of DNA segments between different 
expression platforms in a high-throughput manner, but making the gateway entry clone 
usually involves conventional restriction enzyme based cloning, and this is a major 
drawback of this system. 
DNA vectors that are used in many molecular biology gene cloning experiments need not 
necessarily result in protein expression. Expression vectors are often specifically designed to 
contain regulatory sequences that act as enhancer and promoter regions, and lead to 
efficient transcription of the gene that is carried on the expression vector. The regularly used 
cloning cum expression vectors include pET vectors, pBAD vectors, pTrc vectors etc 
wherein the GOI is cloned with a suitable promoter of the vector using the start codon of the 
vector or using a gene of interest with its own start codon into an apopropriate restriction 
site in the MCS.  
RNA polymerases are enzyme complexes that synthesize RNA molecules using DNA as a 
template. The transcription begins when RNA polymerase binds to the DNA double helix 
which is at a promoter site just  upstream of the gene to be transcribed. While in 
prokaryotes, one DNA-dependent RNA polymerase transcribes all classes of DNA 
molecules and the core Escherichia coli enzyme called E. coli RNA polymerase consists of 
three types of subunit, ǂ, ǃ, and ǃ′, and has the composition ǂ2ǃǃ′; the holoenzyme contains 
an additional σ subunit or sigma factor (Aaron, 2001). The phage RNA polymerase like T7 
RNA polymerase found in pET based expression vectors are much smaller and simpler than 
bacterial ones: the polymerases from phage T3 and T7 RNA, e.g., are single polypeptide 
chains of <100 kDa. 
The DNA fragment to be cloned is first isolated by a number of ways like cDNA 
preparation, nuclease fragments of genomic DNA, synthetic DNA’s, amplified DNA 
fragments by means of polymerase chain reaction. After appropriate restriction enzyme 
digestion and purification, the purified inserts are ligated to the vector of choice.  
2.1.2 Ligation of vector and insert 
The ligation step is carried out with bacteriophage T4 DNA ligase using ATP required for 
the reaction and a suitable buffer condition. This process involves the joining of two DNA 
molecule ends with a phosphodiester bond between the 3' hydroxyl of one nucleotide and 
the 5' phosphate of the other. The ligation event is of two types sticky or blunt based on the 
types of restriction enzyme used for digestion of the vector and insert.  
2.1.3 Transformation 
Following ligation, the ligation product (recombinant plasmid) is transformed into bacteria 
for propagation. The transformed bacteria are then plated on selective agar to select for 
bacteria that have the plasmid of interest. Individual colonies are picked up and tested for 
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the desired insert. The transformation is achieved by chemical method (Hanahan, 1983; 
Inoyue, 1997; Bergmans, 1981) or electroporation (Morrison, 2001).  
2.1.3.1 Chemical transformation 
For transformation of bacterial cells by chemical means, the cells are grown to mid-log 
phase, harvested and treated with divalent cations such as CaCl2 to make them competent. 
After mixing DNA with such competent cells, on ice, followed by a brief heat shock at 42 0C, 
the cells are incubated with rich medium for 30-60 minutes prior to plating on suitable 
antibiotic containing LB agar plates. The biggest advantage of this method includes no 
special equipment for transformation with no requirement to remove salts from the DNA 
used for transformation. 
2.1.3.2 Electroporation 
For electroporation, cells are also grown to mid-log phase but are then washed extensively 
with water to eliminate all salts from the growth medium, and glycerol added to the water 
to a final concentration of 10% so that the cells can be stored frozen and saved for future 
experiments. To electroporate DNA into cells, washed E. coli are mixed with the DNA to be 
transformed and then pipetted into a plastic cuvette containing electrodes. A short electric 
pulse, about 2400 volts/cm, is applied to the cells causing small pores in the membrane 
through which the DNA enters. The cells are then incubated with broth as above before 
plating. For electroporation, the DNA must be free of all salts so the ligations are first 
precipitated with alcohol before they are used.  
2.2 Types of E. coli host cells used for transformation 
For most cloning applications, E. coli k12 hosts like DH5ǂ which are OmpT protease 
expressing cells (Salunkhe etal., 2010) are used. These cells are compatible with lacZ 
blue/white selection procedures, are easily transformed, and good quality plasmid DNA 
can be recovered from transformants. DH5  is one of the most preferred strains for plasmid 
propagation, because it is an EndA1 knockout which inactivates the endonucleases ,and a 
recA knock out which prevents rapid homologous recombination, hence ensuring that the 
plasmids are stable inside the cells. One notable exception is when transforming with 
plasmid constructs containing recombinant genes under control of the T7 polymerase, these 
constructs are typically transformed into DH5 cells during the cloning stage and later 
introduced into a bacterial strain expressing T7 RNA polymerase for expression of the 
recombinant protein. The derivatives available for this purpose include BL21(DE3), BL21A1 
which are all lon and OmpT protease negative strains (Banerjee et al., 2009; Mandi et al, 
2008) and ER2566 (Yu et al., 2004) strains. 
3. Selection of recombinants 
The need to identify the cells that contain the desired insert at the appropriate and right 
orientation and isolate these from those not successfully transformed is of utmost 
importance to researchers. Modern cloning vectors include selectable markers (most 
frequently antibiotic resistance markers) that allow only cells in which the vector, but not 
necessarily the insert, has been transformed to grow. Additionally, the cloning vectors 
may contain color selection markers which provide blue/white screening (via ǂ-factor 
complementation) on X-gal medium. Nevertheless, these selection steps do not 
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absolutely guarantee that the DNA insert is present in the cells. Further investigation of 
the resulting colonies is required to confirm that cloning was successful. This may  
be accomplished by means of PCR, restriction fragment analysis and/or DNA 
sequencing. 
3.1 Colony immunoassay 
Telford et al., (1977) reported identification of bacterial plasmids carrying DNA upon 
lysis and mixing with molten agar with ethidium bromide stain while in as early as  
1978, a colony hybridization was developed for screening recombinants by Cami and 
Kourilsky, (1978) where upon blotting onto nitrocellulose filters and hybridization with a 
highly radioactive probe, screening of many thousands of colonies per plate for the 
presence of a DNA sequence carried by a plasmid and complementary to the probe was 
achieved.  
An immunological approach to screen recombinant clones is possible if the gene of 
interest encodes a polypeptide for which specific antibodies can be prepared. In one 
approach, DNA complementary to mRNA is inserted in frame with the coding regions of 
genes present in E. coli plasmids. These results in "fused polypeptides" consisting of the 
N-terminal region of an E. coli polypeptide covalently linked to a sequence encoded by 
the cloned cDNA segment. The identification of cloned genes by colony immunoassays 
has not been common and one limitation of all previous colony immunoassays is that 
each fused polypeptide molecule must simultaneously bind to two different antibody 
molecules. Typically, the first antibody, immobilized on a solid support such as 
chemically activated paper, is used to entrap the fused polypeptide at the site of the 
lysed colony, and a second labelled antibody is then bound to the fused polypeptide and 
detected by autoradiography. A potential disadvantage of all immunological methods is 
that only one in six sequences inserted at random into the vector would have the 
orientation and frame consistent with translation into a recognizable fused polypeptide. 
Kemp &  Cowman (1981) have described a method by which fused polypeptides can be 
detected by a colony immunoassay that demands binding of only one antibody molecule. 
E. coli colonies containing recombinant plasmids are lysed in situ, and proteins in the 
lysate are immobilized by binding directly to CNBr-activated paper. Antigens attached 
to the paper are then allowed to react with antiserum, and the antibodies that bind to 
them are in turn detected by reaction with 125I-labeled protein A (125I-protein A) from 
Staphylococcus aureus, followed by autoradiography. The limitations of this method are 
mRNA instability, inefficient translation, or rapid proteolytic degradation of the fused 
polypeptides that restrict their accumulation within the cells. 
A simple immunoassay has been developed by Reggie and Comeron (1986) for isolation of 
particular gene(s) from a clone bank of recombinant plasmids. A clone bank of the DNA is 
constructed with a plasmid vector in Escherichia coli and filtered onto a hydrophobic grid 
membrane and grown up into individual colonies, and a replica was made onto 
nitrocellulose paper. The bacterial cells upon lysis are immobilized onto the nitrocellulose 
paper which is reacted with a rabbit antibody preparation made against the particular 
antigenic product to detect the recombinant clone which carries the corresponding gene. The 
bound antibodies can be detected easily by a colorimetric assay using goat anti-rabbit 
antibodies conjugated to horseradish peroxidase.  
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3.2 Visual screening 
3.2.1 The blue-white screening 
The blue white screening is one of the most common molecular techniques that allow 
detecting the successful ligation of gene of interest in vector (Langley et al., 1975; Zamenhof 
& Villarejo 1972; Ausubel et al., 1988). The ǂ-Complementation plasmids are among the 
most commonly used vectors for cloning and sequencing the DNA fragments, as they 
generally have a good multiple cloning site and an efficient blue-white screening system for 
identification of recombinants in presence of a histochemical dye, 5-bromo-4-chloro-3-
indolyl-ǃ-d-galactoside (X-gal), and binding sites for commercially available primers for 
direct sequencing of cloned fragments (Manjula 2004). 
The molecular mechanism for blue/white screening is based on a genetic engineering of the 
lac operon in the E. coli as a host cell combined with a subunit complementation achieved 
with the cloning vector. The lacZ product, a polypeptide of 1029 amino acids, gives rise to 
the functional enzyme after tetramerization (Jacobson et al., 1994) and is easily detected by 
chromogenic substrates either in cell lysates or directly on fixed cells in situ (Ko et al., 1990). 
The tetramerization is dependent on the presence of the N-terminal region spanning the first 
50 residues. Deletions in the N-terminal sequence generate a so-called omega peptide that is 
unable to tetramerize and does not display enzymatic activity. The activity of the omega 
peptide can be fully restored either in bacteria or in vitro, if a small fragment (called alpha 
peptide) corresponding to the intact N-terminal portion is added in trans (Gallagher et al., 
1994). The phenomenon is called α-complementation and the small N-terminal peptide is 
called alpha peptide. This effect has been widely exploited for studies in prokaryotes, where 
special strains that constitutively express omega peptide exist and allow the detection of 
expression of the small alpha peptide.  
The vector (e.g. pBluescript) encodes the ǂ subunit of LacZ protein with an internal multiple 
cloning site (MCS), while the chromosome of the host strain encodes the remaining omega 
subunit to form a functional ǃ-galactosidase enzyme upon complementation. The foreign 
DNA can be inserted within the MCS of lacZǂ gene, thus disrupting the formation of 
functional ǃ-galactosidase. The chemical required for this screen is X-gal, a colorless 
modified galactose sugar that is metabolized by ǃ-galactosidase to form 5-bromo-4-chloro-
indoxyl which is spontaneously oxidized to the bright blue insoluble pigment 5,5'-dibromo-
4,4'-dichloro-indigo and thus functions as an indicator. Isopropyl ǃ-D-1-
thiogalactopyranoside (IPTG) which functions as the inducer of the Lac operon, can be used 
to enhance the phenotype. The hydrolysis of colorless X-gal by the ǃ-galactosidase causes 
the characteristic blue colour in the colonies indicating that the colonies contain vector 
without insert. White colonies indicate insertion of foreign DNA and loss of the cells ability 
to hydrolyze the marker. Bacterial colonies in general, however, are white, and so a bacterial 
colony with no vector will also appear white. These are usually suppressed by the presence 
of an antibiotic in the growth medium. Blue white screening is thus a quick and easy 
technique that allows for the screening of successful cloning reactions through the color of 
the bacterial colony. However, the correct type of vector and competent cells are important 
considerations when planning a blue white screen. 
Although the lacZ and many other systems have been extensively used for gram negative 
bacteria like E. coli, there are limited options available for screening recombinants transformed 
in Gram positive bacteria. Chaffin &  Rubens (1998) have developed a gram positive cloning 
vector pJS3, that utilizes the interruption of an alkaline phosphatase gene, phoZ, to identify 
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recombinant plasmids. A multiple cloning site (MCS) was inserted distal to the region coding 
for the putative signal peptide of phoZ where the alkaline phosphatase protein expressed from 
the phoZ gene (phoZMCS) retained activity similar to that of the native protein and cells 
displayed a blue colonial phenotype on agar containing 5-bromo-4-chloro-3-indolyl phosphate 
(X-p). Introduction of any foreign DNA into the MCS of phoZ produced a white colonial 
phenotype on agar containing X-p and allowed discrimination between transformants 
containing recombinant plasmids versus those maintaining self-annealed or uncut vector. This 
cloning vector has improved the efficiency of recombinant DNA experiments in gram-positive 
bacteria.  
Cloning inserts into the multiple cloning region of the pGEMÂ®-Z Vectors disrupts the 
alpha-peptide coding sequences, and thus inactivates the beta-galactosidase enzyme 
resulting in white colonies. Recombinant plasmids are transformed into the appropriate 
strain of bacteria (i.e. JM109, DH5), and subsequently plated on indicator plates containing 
0.5 mM IPTG and 40 µg/ml X-gal.  
A new version of TA cloning vector with directional enrichment and blue-white color 
screening has been reported by Horn (2005). 
3.2.2 Limitations of blue-white screening 
The "blue screen" technique described above suffers from the disadvantage of using a 
screening procedure (discrimination) rather than a procedure for selecting the clones. 
Discrimination is based on visually identifying the recombinant within the population of 
clones on the basis of a color. The LacZ gene, in the vector used for generating recombinants, 
may be non-functional and may not produce β-galactosidase. As a result, these cells cannot 
convert X-gal to the blue substance so the white colonies seen on the plate may not be 
recombinants but just the background vector. 
A few white colonies might not contain the desired recombinant but a small piece of DNA 
to be ligated into the vector's MCS might change the reading frame for LacZα, and thus 
prevent its expression giving rise to false positive clones. Furthermore, a few linearized 
vectors may get transformed into the bacteria, the ends "repaired" and ligated together such 
that no LacZǂ is produced as a result, these cells cannot convert X-gal to the blue substance. 
On the other hand, in some cases, blue colonies may contain the insert, when the insert is "in 
frame" with the LacZα gene and is devoid of stop codon. This could sometimes lead to the 
expression of a fusion protein that is still functional as LacZǂ. Small inserts which happen to 
be in frame with the alpha-peptide coding region may produce light blue colonies, as beta-
galactosidase activity is only partially inactivated. 
Last but not the least, this complex procedure requires the use of the substrate X-gal which 
is very expensive, unstable and is cumbersome to use.  
3.3 Reporter gene based screening 
Another method for screening and identification of recombinant clones is by using the green 
fluorescent protein (GFP) obtained from jellyfish Aequorea victoria. It is a reporter molecule 
for monitoring gene expression, protein localization, protein-protein interaction etc. GFP has 
been expressed in bacteria, yeast, slime mold, plants, drosophila, zebrafish and in 
mammalian cells. Inouye et al., (1997) have described a bacterial cloning vector with 
mutated Aequorea GFP protein as an indicator for screening recombinant plasmids. The 
pGREENscript A when expressed in E. coli produced colonies showing yellow color in day 
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light and strong green fluorescence under long-UV. Inserted foreign genes are selected on 
the basis of loss of the fluorescence caused by inactivation of the GFP production. The vector 
used in the study is a derivative of pBluescript SK(+) (Short et al., 1998) and encodes for the 
same MCS flanked by T3 and T7 promoters, but lacks the lacZ gene and the f1 origin region 
(for single strand DNA production). Instead, the GFP-S65A cDNA is substituted in its place 
and is under the control of the lac promoter/operator. The insertion of foreign DNAs into 
MCS of pGreenscript A interferes with the production of GFPS65A and causes a loss in the 
green fluorescence and yellow color of E. coli colonies. While GFP solubility appears to be 
one of the limiting factors in whole cell fluorescence, Davis & Vierstra (1998) have reported 
about soluble derivatives of GFP for use in Arabidopsis thaliana.  
A system for direct screening of recombinant clones in Lactococcus lactis, based on secretion of 
the staphylococcal nuclease (SNase) in the organism, was developed by Loir and co-workers 
(Loir et al, 1994). L. lactis strains containing the nuc' plasmids secrete SNase and are readily 
detectable by a simple plate test. An MCS was introduced just after the cleavage site between 
leader peptide and the mature SNase, without affecting the nuclease activity. Cloning foreign 
DNA fragments into any site of the MCS interrupts nuc gene and thus results in nuc mutant 
clones which are easily distinguished from nuc' clones on plates. The biggest advantage of this 
vector is the possibility of assessing activity of the fusion protein since the nuclease activity is 
not diminished by its N-terminal tail and is also reported to be unaffected by denaturing 
agents such as sodium dodecyl sulfate (SDS) or trichloroacetic acid. 
3.3.1 Limitations of the reporter gene based screening 
All the above described plasmids could also result in false positive clones, which is a major 
concern for researchers. Loss of GFP fluorescence due to medium composition is also known 
to lead to false positive results. Although the SNase based screening would give absolute 
100% recombinants, the active nuc fusion protein expression might render the cell fragile 
and enhance its susceptible to the lethal action of the fusion protein upon hyper expression. 
Also, for all the above cases, there is a requirement of transfer the genes of interest from the 
cloning vector to the expression vectors which calls for fresh cloning followed by screening 
for recombinants. 
Hence, it is evident that the commonly used method for screening and identification of 
recombinant clones are associated with problems of false positive results forcing researchers to 
look for alternate methods of screening bacterial recombinants  and availability of  vectors that 
would act both as cloning vectors and expression vector are user friendly and advantageous. 
3.4 Reporter gene based screening- new concepts 
The recent approach of screening recombinants is the use of vector for one-step screening 
and expression of foreign genes (Banerjee et al., 2010) (Fig. 1).  The strategy uses the cloning 
of GFP gene into any expression vector with a stop codon other than the amber stop codon 
upstream of the ORF of GFP.  Upon induction, the GFP would not express and hence would 
not fluoresce due to presence of the stop codon.  Upon in frame cloning of any gene of 
interest upstream of GFP in such a vector, would then excise the initial stop codon and the 
resultant fusion protein would fluoresce.  The gene of interest contains an amber stop codon 
and the recombinant screening is carried out in an amber suppressor E. coli strain.  For 
expression studies, the same clone can be used for expression in a non amber suppressor E. 
coli host like LE392 cells.  
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This report describes a vector where screening the transformants in situ for the presence of 
recombinants is possible without any false positive results. All other commercially available 
vectors show loss of color or loss of fluorescence that may not be unfailing while the major 
advantage of the vector described in this report, takes the property of color or fluorescence 
obtained after cloning. This unique vector would also be applicable with any other reporter 
genes like beta galactosidase gene, luciferase gene, DsRed protein instead of the described 
gene for GFP in the same vector constructed similarly. It also provides researchers to skip 
setting up the control ligation mix (without insert) and the dephosphorylation step (CIP or 
SAP step) since the religated vector would never glow and all the fluorescing colonies are 
indicative of only the recombinants and also indicative of correct reading frame of the 
inserted target gene. Since GFP fluorescence is brightest when it is expressed in soluble form 
(Davis & Vierstra 1998), the intensity of the fluorescence after cloning any foreign gene 
would also indicate the extent of solubility of the fusion protein. The major advantage of the 
vector described in this report, takes the property of color or fluorescence obtained after 
cloning, which is hitherto unreported. Such a vector used for identification, selection and 
expression of recombinants has been patented by the authors (Deshpande etal., 2010) and is 
published under  PCT (Patent no. WO2010/0226601A2) 
 
 
Fig. 1. Plasmid map of the vector pET21aM-GFPm that carries the reporter gene GFP at the 
3’ end of the MCS. AmpR refers to ampicillin resistant marker gene. 
3.5 Screening clones by positive selection 
A variety of positive selection cloning vectors has been developed that allow growth of only 
those bacterial colonies that carry recombinant plasmids. Typically, these plasmids express a 
gene product that is lethal for certain bacterial hosts and insertion of any DNA fragment 
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Positive selection has been a powerful method of screening insert containing transformants. 
Here the toxic property of the molecule to the host cells is utilized for recombinant selection.  
The DNA sequence coding for the toxic product is directly cloned under the promoter 
elements recognized by the host cells. Positive selection in these vectors is achieved by either 
inactivation or replacement of toxic gene by the target gene. In general former is much more 
convenient than the latter (For a detailed review on positive selection vectors ; see reference  
Choi et al., 2002). The advantage of these systems is that no background colonies (non 
recombinants) appear on vector alone plates since the religated vectors carrying toxic intact 
genes are lethal to the host cells.  
The genes of toxin-antitoxin system (Finbarr, 2003) of E. coli are being utilized for the 
development of positive selection vectors. A cloning vector carrying cloned ccdB gene which 
encodes poisonous topoisomerase II (DNA gyrase) causing unrecoverable DNA damage has 
been developed  and is widely used as zero background cloning kit from Invitrogen 
(Bernard 1995). The other toxins from this system which are used successfully are parD and 
parE toxins (Gabant et al., 2000; Kim et al., 2004). Apart from this system, the other toxic 
gene used for the development of positive selection vectors are Colicin E3 and mutated form  
(E181Q) of catabolite activator protein (Ohashi-Kunihoro et al., 2006; Schlieper et al., 1998). 
These powerful selection strategies, however, are often only suitable for cloning and require 
a special host strain for propagation which carry a gene encoding antidote to the product of 
toxic gene. 
The authors of this chapter have developed a positive selection vector which would be used 
for cloning and expression of heterologous genes simultaneously (Mandi et al., 2009). Here 
the toxic gene is derived from the antisense strand of ccdB gene  and cloned under tightly 
regulated araBAD promoter downstream to the multiple cloning sites (Fig. 2). Multiple 
cloning sites facilitate cloning of foreign genes and doesn’t affect the lethality of toxic gene. 
A simple method is used to screen the recombinants in that the transformed cells are plated 
on LB agar medium containing 13 mM arabinose. Moreover, this vector is used also for the 
expression of genes with authentic N-terminus and does not require special host strain for 
its propagation. Recently, Haag & Ostermeier (2009) have also reported the development of 
a novel positive selection vector, RHP-Amps, that is suitable for cloning and high level 
protein expression in E. coli.  Although some limitations exist, positive selection vectors are 
useful in recombinant DNA experiments thereby reducing the time, effort and cost spent on 
identifying the correct clones.  
Some of other well documented lethal genes include bacteriophage λ repressor, EcoRI 
methylase, EcoRI endonuclease, galactokinase, colicin E3, transcription factor GATA-1, lysis 
protein of φX174, barnase (Sambrook et al, 1989), SacB protein of Bacillus subtilis (Gay et al., 
1985), RpsL protein of E. coli (Hashimoto-Gotoh et al., 1993),  and also the ParD system of 
the R1 plasmid (Gabant et al., 2000). 
A recently described strategy by Manjula, (2004) involves the use of galactose sensitivity 
exhibited by galactose epimerase (galE) mutants of Escherichia coli. Here, the E. coli cells that 
are lacZ+ galE, but not lacZ− galE are killed upon addition of lactose due to the 
accumulation of a toxic intermediate, UDP-galactose, by hydrolysis of lactose. Such a 
method has been suggested to be useful during primary cloning experiments such as 
construction of genomic or cDNA libraries and also in instances involving selection for rare 
recombinants. 
www.intechopen.com




Fig. 2. Plasmid map of pBAD24MMCSTG which has a toxic gene under arabinose promoter 
as a HindIII/HindIII fragment and having a MCS for cloning any foreign gene to interrupt 
the expression of the  TG gene to select recombinants based on cell survival in presence of 
the added inducer. 
3.5.1 Potential limitations of screening recombinants based on positive selection  
Requirements of tightly controlled promoter for expression of the anti-dote of the lethal 
gene. Requirements of special host cells for the lethal gene inserted or integrated in the 
bacterial genome is also one of the potential drawbacks and renders this system with limited 
applications. Moreover, since different genes respond to different promoters, requiring 
different kinds of host RNA polymerases, the modification of the host with the required 
lethal gene becomes a prerequisite with various genes which involves cost and is time-
consuming. However, for efficient positive selection, the lethality of the marker gene must 
be strong enough to completely kill the clones harboring vector without insert. 
4. Prediction of solubility of recombinant clones during screening 
The structural and functional genomics require large supply of soluble, pure and 
functional proteins for high throughput analysis and as far as screening of soluble or 
insoluble recombinants is concerned, soluble protein production in E. coli is still a major 
bottleneck for investigators and a couple of efforts have been reported to improve the 
solubility or folding of recombinant protein produced in E. coli (Smith 2007). These 
include strategies like co-expression of chaperone proteins such as GroES, GroEL, DnaK 
and DnaJ lowering incubation temperature, use of weak promoters, addition of sucrose 
and betaine in a growth media, use of a richer media with phosphate buffer such as 
terrific broth (TB), use of signal sequence to export the protein to the periplasmic fraction, 
fermentation at extreme pH’s and use of fusion tags to aid in expression and protein 
purification (De Marco et al., 2004).   
A colony filtration (CoFi) blot method for rapid identification of soluble protein expression 
in E. coli, based on a separation of soluble protein from inclusion bodies by a filtration step 
at the colony level is described to screen a deletion mutagenesis library by Cornvik et al., 
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(2005) while Coleman et al (2004) report a fluorescent based screening of soluble protein 
expression where specifically labeled proteins in cellular lysates are detected in one of three 
formats: a microplate using a fluorescence plate reader, a dot-blot using a fluorescence 
scanner or a microarray using a laser scanner. 
Fusion tags have become indispensable tools for structural and functional proteomics 
initiatives (Banerjee et al., 2010). Fusion tags that are available for the ease of expression 
and purification of recombinant proteins  include His tag (6-10 aa) (Smith et al., 1988), 
thioredoxin (109 aa) (Lavallie et al., 1993), Glutathione S-transferase (236 aa) (Smith & 
Johnson 1988), maltose binding protein (363 aa) (di Guan et al., 1998),  NusA (435 aa) 
(Davis et al., 1999) etc.  Although these tags are mainly used  to promote the solubility of 
the target proteins and there by prevent the formation of inclusion bodies in E. coli, its 
use in screening recombinants for solubility of protein of interest is also demonstrated.  
Maxwell et al., (1999) report cloning of a gene of interest as chloramphenicol acyl 
transferase (CAT) fusion. Based on the resistance to higher concentration of 
chloramphenicol, it would be easier to predict the solubility of target protein. The 
authors have developed an in vivo system for assessing protein or protein domain of 
interest with CAT, the enzyme responsible for conferring bacterial resistance to 
chloramphenicol. CAT is highly soluble homodimeric protein that has shown to maintain 
activity when fused to various other proteins. It has been observed that CAT fusions to 
insoluble proteins confer lower chloramphenicol resistance than that of a fusion with 
highly soluble partner.  
Similarly, Banerjee et al., (2010) have shown that the solubility of the target protein could 
be predicted in situ at the time of recombinant screening based on the intensity of the 
GFP fusion proteins. This work demonstrates that higher the solubility of the target 
protein , the intensity of the GFP fluorescence on the agar plate is higher rendering the 
screening of the recombinants a dual objective of identification and also predicting the 
solubility of the gene of interest attached to the reporter gene. The article as described by 
Banerjee et al., (2010) demonstrates this clearly. While GCSF, a human granulocyte 
colony stimulating factor gene which is known to get expressed as insoluble aggregates 
in E. coli shows lesser fluorescence as GFP fusion (Figure 3, panel B) the E. coli 
methionine amino peptidase, the well soluble E. coli protein exhibits higher intensity of 





A     B 
 
 
Fig. 3. Photograph showing two examples of GFP fusions in the pBAD24mGFP vector to 
demarcate the solubility difference by means of fluorescence. Panel A shows the E. coli 
methionine amino peptidase GFP fusion E. coli clone under long UV while Panel B shows 
GCSF-GFP fusion clone fluorescence under long UV. Higher glow indicates higher 
solubility. Clones #3 refers to a non-recombinant in case of MAP-GFP fusion while clone #2 
and 5 are non-recombinants of GCSF-GFP fusions. 
MAP-GFP fusion clones GCSF-GFP fusion clones 
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A similar strategy has been reported by Colman and Homes (2005) for integration 
confirmation in Pseudomonas strains. Here a pUC-based reporter plasmid (pUS23) was 
developed containing a recombination site [aadB 59 base element (59-be)] upstream of 
promoterless aadB [gentamicin (Gm) resistance] and gfp (green fluorescence) genes, and 
this construct was used to investigate the recombination and expression activities of the CI 
in Pseudomonas stutzeri strain Q capture of pUS23 at attI by an integron results in Pc-
mediated expression of the aadB and gfp genes, which are silent in the initial construct. 
The final end result is gentamicin resistant and green fluorescent recombinants for 
positive integrants.  
5. Conclusions 
In this article, we have summarized some updated information about (1) new vectors that 
are commercially available to make the screening system of bacterial recombinants antibiotic 
free (2) new concepts about easy screening of recombinants utilizing the solubility property 
of the protein of interest and (3) specialized host strains and using the same clone for 
expression studies.  
Developments in recombinant DNA technology have allowed rapid progress in the analysis 
of gene structure and function, and the production of potentially useful polypeptides in 
Escherichia coli. Often the experimentally limiting step has been the lack of a suitable 
screening methodology for expressed cDNAs. The extensive variety of screening bacterial 
colonies for recombinant plasmids arises from the fact that there is no single method for 
achieving fool-proof recombinant clone.  Conventionally the screening methods employed 
routinely in academia and industry, for bacterial recombinants include colony 
hybridization, PCR and plasmid preparations. While all the methods  involve cloning the 
gene of interest in a cloning vehicle and then reintroduction of the recombinant clone into 
another host cell for expression of the interest making the entire process time-consuming, 
laborious and expensive. While colony hybridizations require several days to a week and 
may involve the use of radioactivity, PCR based methods are expensive and have lengthy 
set-up and reaction times, plasmid preps require considerable hours for cell growth and 
preparation of mini-prep plasmids. An additional step of screening such recombinants for 
the solubility of the protein of interest makes the entire process labor-intensive and 
challenging.   
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